This unique international conference provides a platform for researchers and decision makers in biotechnology to present their latest findings and learn about all the important developments in biotechnology. Many Nobel Laureates and world's renowned experts will participate in the conference.

The conference will cover the translational nature of biotechnological research, with emphasis on both the basic science as well as its applications in industry and academia. Presentations will include major research advances in biotechnology, business development, strategic alliances, partnering trends, product opportunities, growth business models and strategies, licensing and pharmaceutical biotechnology (e.g. vaccines, CNS, cancer, antibodies), medical biotechnology, industrial biotechnology, bioprocess engineering, protein engineering, plant and environmental technologies, transgenic plant and crops, bioremediation, and microbial diversity research.

Throughout the course of the four day conference, you will have the opportunity to both network and hear leaders from the international academic and corporate biotechnology communities.

The conference is organized by Eureka Conference.

Deadline for Abstract submission - 1^st Aug 2012 -  15^th April, 2013

 Early Bird Registration Offer Valid till 31^st January, 2013
Deadline for Conference Registration – 1^st May 2013

A two day registration option is also available

Abstracts for consideration as Invited or Session Lectures, and Poster Presentations may be submitted at http://translationalmedicine-cong.com/reg.htm or alternatively  at editorial@ainfect-cong.com

3. Conference Tracks

   Pharmaceutical Biotechnology: biopharmaceuticals discovery (CNS, cancer, cardiovascular, endocrine, immune); vaccines; antibodies; protein engineering.


4. Plant and Environment: transgenic plants and crops; bioremediation; microbial diversity; bio-monitoring; photosynthetic microorganisms, cyanobacteria and microalgae.


5. Industrial and Manufacturing: bio-fuels; energy crops (cellulosic ethanol industry); industrial enzymes; bioprocess engineering and optimization.


6. Medical Biotechnology: biopharmaceutical manufacturing; diagnostics; imaging; pharmacogenomics (personalized medicine); microarray technology; biomarkers.


7. Business Development: strategic alliances; partnering trends; product opportunities; growth; business models and strategies; licensing; merger and acquisitions; outsourcing; venture capital and financing; intellectual property.


8. Regenerative Medicine: stem cells, gene therapy; tissue engineering; cell based therapy; cell cultivation.


9. Other areas: Food; Marine; Bio-safety; Systems Biology, Clinical Research/clinical trials; bioethics; nanobiotechnology.